Cardiff Oncology Inc (FRA:XE7C)
€ 2.975 -0.145 (-4.65%) Market Cap: 142.29 Mil Enterprise Value: 82.00 Mil PE Ratio: 0 PB Ratio: 2.53 GF Score: 50/100

Cardiff Oncology Inc Clinical and Corporate Update Call Transcript

Aug 07, 2023 / 09:00PM GMT
Release Date Price: €1.45 (-5.59%)
Operator

Welcome to the Cardiff Oncology conference call to discuss the company's mCRC program update and development plan. (Operator Instructions) As a reminder, this call is being recorded today, Monday, August 7, 2023. I would now like to turn the conference call over to Laurence Watts of Gilmartin Group. Please go ahead.

Laurence Watts
Gilmartin Group LLC - IR

Thank you, operator. Slides for today's investor call can be found on the homepage and the events and presentations tab of the Cardiff Oncology-website at www.cardiffoncology.com. Joining us on the call today from Cardiff Oncology are Chief Executive Officer, Mark Erlander; Chief Medical Officer, Fairooz Kabbinavar; Chief Scientific Officer, Tod Smeal; Chief Financial Officer, Jamie Levine; and Senior Vice President of Regulatory Affairs, Charles Monahan.

Please turn to Slide 2. During this conference call, management will make forward-looking statements, including, without limitation, statements related to guidance, results, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot